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PREVALENCE OF ANXIETY AND DEPRESSION IN 
CAREGIVERS OF ALZEHEIMER’S DEMENTIA PATIENTS 
Draženka Ostojić, Domagoj Vidović, Ana Bačeković, Petrana Brečić and Vlado Jukić
Vrapče University Psychiatric Hospital, Zagreb, Croatia
SUMMARY – Alzheimer’s dementia (AD) is the most common neurodegenerative disorder, which affects 
30 million people worldwide. With aging of the population, it is becoming an increasing problem in Croatia. 
Alzheimer’s dementia represents not only problem for the patient but affects the patients’ caregivers as well. 
Caring for a patient with AD carries a significant physical, socioeconomic and psychological burden. Previous 
studies have shown an increased risk of physical and psychiatric illness. The aim of our study was to evaluate 
the prevalence and intensity of anxious and depressive symptoms in caregivers of AD patients treated at Vrapče 
University Psychiatric Hospital in Zagreb. The study included 30 caregivers of AD patients. Participants were 
included consecutively, during July and August 2010. The Croatian version of the Hospital Anxiety and De-
pression Scale (HADS) was used to assess the level of anxiety and depression in study participants. The mean 
level of anxiety and depression as measured by HADS was 10.46±4.26 and 8.03±4.08, respectively. A patho-
logic level of anxiety was found in 14 (46.7%) and pathologic level of depression as measured by HADS in 8 
(26.7%) caregivers. This study showed that not only appropriate treatment of AD patients is necessary, but AD 
patient caregivers should also be provided due care and support. 
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Introduction
Alzheimer’s dementia (AD) is a progressive, de-
generative disease of the central nervous system, which 
affects memory, mind and behavior of the patient. It is 
the most common neurodegenerative disorder in the 
world, which affects almost 30 million people1. The 
consequence of the disease is loss of everyday func-
tioning and therefore an increased need of nursing 
care by other persons. 
Large studies and epidemiological reports point 
to several risk factors for development of AD. Age of 
the patient is the most important risk factor; dementia 
affects 10% of people aged >65, with a higher inci-
dence in women. The incidence of AD increases with 
age. In people aged 60-64, the prevalence of AD is 
1%-3%, in those aged 70-80 it is 3%-12%, and the 
proportion increases to as high as 25%-35% in people 
older than 802. Other risk factors are mutations of the 
genes for apolipoprotein E (apoE) and for early onset 
disease, mutations in the genes for amyloid precursor 
protein (APP), presenilin (PS 1 and PS 2)3,4. Also, 
other potential risk factors include history of head 
trauma, lower education level, inflammation and obe-
sity5-7. With aging of the population in Croatia, the 
AD problem increases.
Alzheimer’s dementia poses a problem not only for 
the patient but also has significant consequences on 
the patient’s caregivers. It is known that caring for a 
patient with AD contributes to physical and psychi-
atric illness and increases the risk of death8-10. It also 
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has a significant economic impact on caregivers. Pro-
gressive cognitive impairment leads to considerable 
loss of physical capabilities and increases the need of 
care by other persons. Caring for a patient with AD 
is a permanently frustrating situation with everyday 
duties, changing the caregiver’s life profoundly. It re-
quires time, will, patience, energy and physical effort. 
Numerous and everyday changes are needed to follow 
the progressive and irreversible changes in the patient 
with AD8,9. 
Most frequently, the persons caring for patients 
with AD are members of their families. In recent 
time, family has suffered significant changes and has 
transformed from large numbered to small, two or 
three member communities, therefore the number of 
persons caring for the patient with AD has decreased. 
Often, the spouses of AD patients are elderly per-
sons with several chronic diseases, which additionally 
worsens the problem. AD leaves no hope for recovery, 
it unknowingly increases anxiety regarding one’s fu-
ture and death, physical deterioration of the patient 
changes the family dynamics, and constant need of 
energy and physical work leads to exhaustion and 
worsening of the physical status of older family mem-
bers. Sudden, unexpected and sometimes aggressive 
reactions of the patient are a risk factor for develop-
ment of mental disturbances in caregivers. In com-
bination with the duration of AD, all these changes 
leave trace on physical and mental health of persons 
caring for AD patients. Previous studies have shown 
that caregivers of AD patients can develop anxious 
and depressive symptoms, or even complete clinical 
picture of depressive and anxiety disorder10.
The aim of our study was to assess the prevalence 
and intensity of anxious and depressive symptoms in 
caregivers of AD patients treated at Vrapče University 
Psychiatric Hospital in Zagreb, Croatia. 
Patients and Methods
Thirty caregivers of AD patients admitted to 
Vrapče University Psychiatric Hospital were included 
in the study. AD was diagnosed using the Diagnostic 
and Statistical Manual of Mental Disorders IV (DSM 
IV) criteria11. Participants were included consecu-
tively, during July and August 2010. The study was 
approved by the Hospital Ethics Committee. All par-
ticipants or their caregivers had signed the informed 
consent before inclusion in the study. 
In this study, we used a specially structured ques-
tionnaire consisting of two parts. In the first part, 
general data of the participants were collected: age, 
gender, relation with the patient, level of education, 
living with the patient, number of inmates, number of 
months/years living with the patient, socioeconomic 
status, and number of hours per day the caregiver was 
spending with the AD patient. In the second part, the 
Croatian version of the Hospital Anxiety and Depres-
sion Scale (HADS) was used to evaluate the level of 
anxiety and depression of the participants. HADS is 
a rating scale that measures the level of anxiety and 
depression12. The scale has been validated and proved 
useful in detecting clinically significant level of anxiety 
and depression in various groups of participants. The 
questionnaire consists of 14 questions, 7 on depression 
and 7 on anxiety, and it takes 3-5 minutes to take the 
test. Results for both groups (anxiety and depression) 
are expressed on the 0-21 scale. Results of 8-10 de-
note a borderline value, while results of ≥11 indicate a 
clinically significant value. It is considered that, in an 
attempt to reach optimal balance between sensitivity 
and specificity, values above 8 should be considered 
clinically significant on both scales13-15. Results were 
processed by use of descriptive statistics.
Results 
We included 30 participants, 22 (73.3%) females 
and eight (26.7%) males, mean age 57.6. Medium or 
high level of education (high school and university) 
had 83.4% of caregivers, 63.3% lived in the same place 
with the patient, 53.3% had medium social status, and 
56.6% lived in a house. The mean number of people 
living in the same household with the patient was 
1.56±1.16. The majority of caregivers were children 
living with parents suffering from AD (63.3%). The 
time of living with AD patient ranged from 3.34 to 
51.7 years (27.56±24.22), while the time elapsed from 
AD diagnosis was 0.67 to 5.43 years. Caregivers spent 
a mean of 16.43±9.93 hours a day with the patient. 
Demographic and general data are shown in Table 1. 
The mean level of anxiety as measured by HADS 
was 10.46±4.26 and the mean level of depression was 
8.03±4.08. A pathologic level of anxiety was found in 
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14 (46.7%) caregivers, while eight (26.7%) caregiv-
ers had pathologic levels of depression as measured 
by HADS. If caregivers with borderline values as 
measured by HADS (8-11) had been included, then 
pathologic values on anxiety scale would have been 
present in more than 76.7% and pathologic values on 
depression scale in 56.7% of caregivers (Table 2).  
Discussion
As expected, study results revealed a high level 
of anxiety and depressive symptoms in persons car-
ing for AD patients. Previous reports have shown the 
prevalence of anxiety in persons caring for AD pa-
tients to range from 3.7% to 76.5%. These differences 
in the results are caused by using different scales, time 
of observation and methodology on making the diag-
nosis of AD16. Almost every depression is associated 
with anxiety, while anxiety is not necessarily associ-
ated with depression17. This was the reason for the 
lower incidence of depressive symptoms in our par-
ticipants, which is consistent with literature data. The 
prevalence of depressive disorder in caregivers of AD 
patients varies from 15% to 32%18. It should be noted 
that these data include patients with the diagnosis of 
depressive disorder, not depressive symptoms. 
According to the literature, the risk factors for 
anxiety symptoms in persons caring for AD patients 
are female sex, lower subjective feeling of physical 
health, living with the patient, incommodious rela-
tionship with the patient, and higher level of physical 
disability19. The risk factors for depressive symptoms 
in people taking care for AD patients are female sex, 
younger age, aggression of the patient, and more time 
spent with the patient. 
The limitations of our study were a relatively small 
number of subjects and inclusion of participants from 
a single hospital. It is also important to note that we 
included only one person per patient. There is a pos-
sibility that people with different levels of anxiety and 
depression are included in care for one AD patient. 
It is known that AD affects not only the patient but 
also changes the life of the whole family. Complexity 
of treatment, constant care for the patient, insuffi-
ciency of social and health system, and high expenses 
have great impact on the caregivers of AD patients. 
The high levels of anxiety and depression in caregivers 





























Mean number of people living with 
the patient 1.56±1.16
Living with the patient (yrs) 27.56±24.22















Hours of caring for patient/day 16.43±9.93
AD = Alzheimer’s dementia
Table 2. Hospital Anxiety and Depression Scale (HADS) 
score median values for anxiety and depression and num-
ber of subjects according to HADS groups
Anxiety Depression
HADS score (median ± 
standard deviation) 10.46±4.26 8.03±4.08
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recorded in our study pointed to the need of providing 
care to the caregivers. This study has shown that car-
ing for AD patient has an unfavorable impact on the 
health of a caregiver. Except for treatment and care 
for the patient, it is important to develop programs for 
prevention and treatment of mental disorders of the 
caregivers. 
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Sažetak
UČESTALOST ANKSIOZNOSTI I DEPRESIJE KOD OSOBA KOJE NJEGUJU BOLESNIKE S 
ALZHEIMEROVOM DEMENCIJOM
D. Ostojić, D. Vidović, A. Bačeković, P. Brečić i V. Jukić
Alzheimerova demencija (AD) je najčešći neurodegenerativni poremećaj koji zahvaća više od 30 milijuna ljudi u svi-
jetu, a starenjem populacije postaje rastući problem i u Hrvatskoj. Alzheimerova demencija ne predstavlja problem samo 
oboljelima, već i njegovateljima također. Briga o bolesnicima s AD predstavlja značajan fizički, socioekonomski i psiho-
loški teret. Prethodna istraživanja su pokazala povećan rizik od fizičkih i psihičkih bolesti. Cij našega istraživanja bio je 
procijeniti učestalost i težinu anksioznih i depresivnih simptoma kod njegovatelja bolesnika s AD u Klinici za psihijatriju 
Vrapče u Zagrebu. Istraživanje je uključilo 30 njegovatelja bolesnika s AD. Sudionici istraživanja su uključeni tijekom 
srpnja i kolovoza 2010. g. Hrvatska verzija Hospital and Depression Scale (HADS) je korištena za procjenu anksioznosti i 
depresije. Prosječne razine anksioznosti i depresije bile su  10,46±4,26 i 8,03±4,08. Patološka razina anksioznosti je nađena 
kod 14 (46,7%) njegovatelja, a patološka razina depresije kod 8 (26,7%) njegovatelja. Ova studija pokazuje da je uz odgo-
varajuću terapiju bolesnika s AD potrebna i primjerena briga i potpora njegovateljima. 
Ključne riječi: Alzheimerova bolest; Demencija; Aksioznost – epidemiologija; Anksioznost – dijagnostika; Depresivni poreme-
ćaji – epidemiologija; Depresivni poremećaji – dijagnostika; Njegovatelji; Psihijatrijski status, procjena stupnja
